期刊文献+

慢性肾脏病患者干扰素γ的表达及其临床意义 被引量:4

The clinical study of IFN-γ expression in chronic kidney disease patients
下载PDF
导出
摘要 目的检测慢性肾脏病(CKD)患者血清中干扰素γ的表达情况,评价它们在临床实践中的价值。方法收集24例慢性肾脏病患者,根据肾小球滤过率分为CKD 1-2期组、CKD 3-4期组和CKD 5期组,另外收集24例健康成人为对照组。用外周血标本检测四组患者的干扰素γ,并常规检查血尿素氮、肌酐、血脂和肾小球滤过率,并进行对比分析。结果 CKD各期患者与对照组的年龄、性别、体重指数间差异无统计学意义(P〉0.05)。CKD 5期组患者血清干扰素γ的表达均高于对照组、CKD 1-2期组和CKD 3-4期组,差异均有统计学意义(P〈0.05)。在校正了慢性肾脏病患者的年龄、性别、体重指数后,其肾小球滤过率、C反应蛋白和脂联素与血清干扰素γ独立相关。结论慢性肾脏病患者的血清干扰素γ水平明显升高,与肾脏病进展相关,并与肾功能的变化独立相关。 Objective To detect the serum interferon γ(IFN-γ) of patients with chronic kidney disease(CKD), and investigate the value of IFN-γ in clinical practice. Methods Twenty-four cases of patients with chronic kidney disease were divided into CKD 1~2 stage group, CKD 3~4 stage group, and CKD 5 stage group according to their stage of the disease, and another 24 cases of healthy people were classified to control group. The IFN-γ of peripheral-blood specimens in the four groups were detected, and blood urea nitrogen, creatinine, blood lipids and glomerular filtration rate were detected and compared. Results The age, sex and IBM of patients in the four groups have no significant difference(P〈0.05). The level of serum IFN-γ in CKD 5 stage group are higher than that in control group, CKD 1~2 stage group and CKD 3~4 stage group,the difference are significant(P〈0.05, respectively). After revising the age, sex and IBM of CKD patients, the glomerular filtration rate, C-reactive protein, and adiponectin are independently associated with IFN-γ. Conclusion The level of serum IFN-γ in CKD patients are significantly increased. It is related to the progress of renal disease, and is independently associated with the changes of renal function.
出处 《临床医学研究与实践》 2016年第9期1-2,6,共3页 Clinical Research and Practice
关键词 干扰素Γ 慢性肾疾病 肾功能不全 interferon γ chronic kidney disease renal insufficiency
  • 相关文献

参考文献3

二级参考文献44

  • 1郑焱,王进红.糖尿病肾病与炎症因子纤溶酶原激活物抑制物-1、超敏C反应蛋白的相关性研究[J].苏州大学学报(医学版),2005,25(3):483-484. 被引量:4
  • 2王惠萍,杨长虹,毛云英.原发性肾病综合征患儿白细胞介素-4、γ-干扰素与激素疗效的关系[J].西安交通大学学报(医学版),2006,27(5):483-485. 被引量:8
  • 3Terkeltaub R,Zachariae C,Santoro D,et al.Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation[J].Arthritis Rheum,1991,34(7):894-903.
  • 4van Lieshout AW,Fransen J,Flendrie M,et al.Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis[J].Ann Rheum Dis,2007,66(10):1334-1338.
  • 5van der Voort R,van Lieshout AW,Toonen LW,et al.Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints[J].Arthritis Rheum,2005,52(5):1381-1391.
  • 6Ruth JH,Haas CS,Park CC,et al.CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway[J].Arthritis Rheum,2006,54(3):765-778.
  • 7Gutwein P,Abdel-Bakky MS,Schramme A,et al.CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein[J].Am J Pathol,2009,174(6):2061-2072.
  • 8Ruth JH,Arendt MD,Amin MA,et al.Expression and function of CXCL16 in a novel model of gout[J].Arthritis Rheum.2010,62(8):2536-2544.
  • 9Wallace SL,Robinson H,Masi AT,et al.Preliminary criteria for the classification of the acute arthritis of primary gout[J].Arthritis Rheum,1997,20(3):895-900.
  • 10Zhang W,Doherty M,Pascual E,et al.EULAR evidence based recommendations for gout.Part I:Diagnosis.Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)[J].Ann Rheum Dis,2006,65(10):1301-1311.

共引文献12

同被引文献58

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部